熱門資訊> 正文
Dogwood Therapeutics重新遵守纳斯达克最低出价规则
2024-10-30 21:22
- Dogwood Therapeutics (NASDAQ:DWTX), formerly known as Virios Therapeutics, has regained compliance with Nasdaq's minimum bid price requirement.
- DWTX shares were trading +0.90% Wednesday pre-market.
- The biopharmaceutical company said the listing compliance matter is now closed.
- Source: Press Release
More on Virios Therapeutics
- Virios, and Wex Pharmaceuticals report business combination to form Dogwood Therapeutics
- Seeking Alpha’s Quant Rating on Virios Therapeutics
- Historical earnings data for Virios Therapeutics
- Financial information for Virios Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
